Summary

89.41 -1.32(-1.45%)07/11/2025
Nasdaq, Inc. (NDAQ)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 Years
-1.45-1.263.3425.3818.1345.60133.81


Last 730 data points are shown. To view all data, Upgrade to PRO plan!


Fundamental Ratings
CategoryRating
Main RatingB
Recommended RatingNeutral
DCFBuy
ROEBuy
ROABuy
Debt/EquitySell
P/EStrong Sell
P/BStrong Sell


Earnings
  • NDAQ reported last earnings on 2025-04-24 after the market.
  • An EPS of $0.79 was observed compared to an estimated EPS of $0.771, resulting in a surprise value of $0.02.
  • A revenue of $2,090 million was observed compared to an estimated revenue of $1,231 million, resulting in a surprise value of $859 Million.


  • Trading Data
    Close89.41
    Open90.27
    High90.37
    Low89.33
    Volume2,433,430
    Change-1.32
    Change %-1.45
    Avg Volume (20 Days)3,334,888
    Volume/Avg Volume (20 Days) Ratio0.73
    52 Week Range61.42 - 90.84
    Price vs 52 Week High-1.57%
    Price vs 52 Week Low45.57%
    Range0.00
    Gap Up/Down-0.57
    Profitibility
    Market Capitalization (Mln)51,034
    Revenue per share13.5850
    Net Income per share2.2221
    Dividend Yield0.0138
    Dividend Share123.00%
    Valuations
    Enterprise Value0.00%
    PE Ratio40.2359
    PB Ratio0.0000
    PTB Ratio0.0000
    Liquidity
    Debt/Equity Ratio0.0000
    Net Debt/EBIDTA Ratio0.0000
    Current Ratio0.0000
    Enterprise Value and Cash Flow
    EV/Sales Ratio0.0000
    EV/EBIDTA Ratio0.0000
    EV/Free Cash Flow Ratio0.0000


    07/11 16:05 EST - globenewswire.com
    Delisting of Securities from The Nasdaq Stock Market
    NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.'s securities were suspended on March 5, 2025 and have not traded on Nasdaq since that time.
    07/10 11:15 EST - zacks.com
    NDAQ Outperforms Industry, Trades at Premium: How to Play the Stock
    Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
    07/09 02:14 EST - seekingalpha.com
    Nasdaq Keeps The Bulls Charging, Proving It Can Grow And Profit Amid Volatility
    I'm reaffirming my prior buy rating on Nasdaq from summer 2023, seeing continued longer-term upside potential in this firm. Despite a share price topping its 5-year high, further investor bullishness can come from strong profit margins, top-line growth factors, and a sector getting tailwind from...
    06/30 16:45 EST - globenewswire.com
    Indigo Acquisition Corp. Announces Pricing of $100,000,000 Initial Public Offering
    NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Indigo Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The Company's units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow,...
    06/30 14:40 EST - seekingalpha.com
    The Death Of Buy And Hold Has Been Greatly Exaggerated
    Market indices are strong, but underlying breadth and momentum are weakening, notes David Keller, suggesting limited upside and a better buying opportunity later in the year. Tech remains the leading sector, though valuations are stretched.
    06/30 09:15 EST - globenewswire.com
    Senti Bio Participates in Nasdaq Amplify Spotlight Series
    Access the segment here
    06/26 19:00 EST - globenewswire.com
    FIGX Capital Acquisition Corp. Announces the Pricing of $131,000,000 Initial Public Offering
    Tiburon, CA, June 26, 2025 (GLOBE NEWSWIRE) -- FIGX Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 13,100,000 units. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading tomorrow, June...
    06/26 15:07 EST - globenewswire.com
    LightWave Acquisition Corp. Announces Closing of $215,625,000 Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option
    Dallas, TX, June 26, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the closing of its initial public offering of 21,562,500 units at an offering price of...
    06/26 02:00 EST - globenewswire.com
    Nasdaq and QCP Set New Standard of Capital Efficiency by Connecting Canton Network to Nasdaq Calypso
    Use case demonstrates the ability to enhance institutional risk management by integrating on-chain capabilities Use case demonstrates the ability to enhance institutional risk management by integrating on-chain capabilities
    06/25 19:16 EST - zacks.com
    Non-Tech Markets Lose Steam; Nasdaq Approaches Record High
    The Dow slipped 106 points, -0.25%, while the Nasdaq gained +61 points, +0.31% -- approaching new highs.
    06/25 18:06 EST - youtube.com
    Trade It of Fade It: JPM, GEV, IBM, CRWD, NDAQ
    'Fast Money' traders talk if they would trade or fade stocks that are hitting or nearing record highs.
    06/24 18:44 EST - globenewswire.com
    LightWave Acquisition Corp. Announces Pricing of $187,500,000 Initial Public Offering
    Dallas, TX, June 24, 2025 (GLOBE NEWSWIRE) -- LightWave Acquisition Corp. (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 18,750,000 units at an offering price of...
    06/24 17:25 EST - globenewswire.com
    Oxley Bridge Acquisition Limited Announces the Pricing of $220,000,000 Initial Public Offering
    Vancouver, BC, June 24, 2025 (GLOBE NEWSWIRE) -- Oxley Bridge Acquisition Limited (the “Company”) announced today the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Global Stock Market LLC...
    06/24 09:46 EST - benzinga.com
    Nasdaq Surges 1%; TD Synnex Posts Upbeat Earnings
    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 1% on Tuesday.
    06/24 08:31 EST - zacks.com
    Buy 5 High-Flying Non-Tech Nasdaq-Listed Stocks of H1 to Gain in H2
    Nasdaq is flat in first-half 2025, but SFM, RGLD, TRI, WWD and EXEL are soaring, each up over 20% and primed for the second half.
    06/24 08:23 EST - proactiveinvestors.com
    Nasdaq likely to extend rally after Trump hails Israel-Iran ceasefire, sending oil prices tumbling
    US stock futures are set to extend their gains on Tuesday, after Donald Trump oversaw a ceasefire deal agreement between Israel and Iran that sent oil prices tumbling.  Futures contracts for the S&P 500 were up 0.7%, while those for the tech-heavy Nasdaq gained almost 1% and Dow Jones futures were...
    06/24 07:00 EST - globenewswire.com
    Brera Holdings Announces Reverse Share Split to Regain Compliance with Nasdaq's Minimum Bid Price Rule
    Dublin, Ireland, June 24, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC (“Brera Holdings” or the “Company”) (Nasdaq: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men's and women's sports clubs through a multi-club ownership (“MCO”)...
    06/24 05:40 EST - globenewswire.com
    Garden Stage Limited Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
    Hong Kong, June 24, 2025 (GLOBE NEWSWIRE) -- Garden Stage Limited (NASDAQ: GSIW) (“GSIW” or the “Company”), today announced that on June 23, 2025, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company...
    06/23 16:15 EST - globenewswire.com
    Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in connection with the appointment of Anne Marie Cook...